A. Srirangam

Temporal quantitative proteomics by iTRAQ 2D-LC-MS/MS and corresponding mRNA expression analysis identify post-transcriptional modulation of actin-cytoskeleton regulators during TGF-beta-Induced epithelial-mesenchymal transition.

R. Kuick, G. Omenn, V. Keshamouni, 2009, Journal of proteome research.

Calpain Regulates Enterocyte Brush Border Actin Assembly and Pathogenic Escherichia coli-mediated Effacement*

A. Srirangam, D. Brocks, D. Potter, 2003, Journal of Biological Chemistry.

Effects of HIV Protease Inhibitor Ritonavir on Akt-Regulated Cell Proliferation in Breast Cancer

Christie M. Orschell, A. Srirangam, Lang Li, 2006, Clinical Cancer Research.

The Human Immunodeficiency Virus Protease Inhibitor Ritonavir Inhibits Lung Cancer Cells, in Part, by Inhibition of Survivin

A. Srirangam, A. Rizzardi, D. Potter, 2011, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Expression of the unconventional myosin Myo1c alters sodium transport in M1 collecting duct cells.

A. Srirangam, M. Wagner, J. Pennington, 2005, American journal of physiology. Cell physiology.

Chemotherapeutic Drugs Induce PPAR-γ Expression and Show Sequence-Specific Synergy with PPAR-γ Ligands in Inhibition of Non–Small Cell Lung Cancer

V. Keshamouni, A. Srirangam, T. Standiford, 2008 .

Ischemia disrupts myosin Iβ in renal tubules

A. Srirangam, M. Wagner, J. Boyd-White, 2001 .

Alloimmune and Skin Allograft Responses in 4-1BB (CD137)-deficient Mice

A. Srirangam, B. Kwon, J. Suh, 2002 .

In vitro modulation of proliferation and melanization of melanoma cells by citrate

A. Srirangam, V. Bhatnagar, R. Abburi, 1998, Molecular and Cellular Biochemistry.

HPV16 E5 protein disrupts the c-Cbl–EGFR interaction and EGFR ubiquitination in human foreskin keratinocytes

A. Srirangam, D. Potter, Benyue Zhang, 2005, Oncogene.

Prediction of Postoperative Recurrence-Free Survival in Non–Small Cell Lung Cancer by Using an Internationally Validated Gene Expression Model

Ranjana Mitra, Xianghua Luo, Monica Milani, 2011, Clinical Cancer Research.

Chemotherapeutic drugs induce PPAR-gamma expression and show sequence-specific synergy with PPAR-gamma ligands in inhibition of non-small cell lung cancer.

V. Keshamouni, A. Srirangam, T. Standiford, 2008, Neoplasia.